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Abstract 
For a conducting polymer (CP) based drug release system, drug loading is often 
accomplished by a doping process, in which drug is incorporated into polymer as 
dopant. Therefore, the drug loading capacity is relatively low and the range of drugs 
can be loaded is limited. In the present work, a polypyrrole (PPy) nanowire network 
is prepared by an electrochemical method and it is found that the micro- and nano- 
gaps among the individual nanowires of the PPy nanowire network can be used as 
reservoir to store drugs. Therefore, the drug loading capacity is dependent on the 
volume of these micro- and nano-vacancies, instead of the doping level. The range 
of loaded drugs also can be theoretically extended to any drugs, instead of only 
charged dopants. In fact, it is conﬁrmed here that both hydrophilic and lipophilic 
drugs can be loaded into the micro- and nano-gaps due to the amphilicity of the PPy 
nanowire network. As a result, both drug loading capacity and the range of drugs can 
be loaded are signiﬁcantly improved. After being covered with a protective PPy ﬁlm, 
controlled drug release from the prepared system is achieved by electrical 
stimulation (cyclic voltammetry, CV) and the amount of drug released can be 
controlled by changing the scan rate of CV and the thickness of the protective PPy 
ﬁlm. 
 
1. Introduction 
Nanostructured conducting polymers (CPs) have been one of the focus research 
topics in the ﬁeld of nanoscience for a number of years. To date, numerous 
nanostructures of CPs, such as nanowire, nanowire network, nanorod, nanotube, 
nanoparticle, and nanobelt have been synthesized and studied [1–4]. Among these 
CP nanostructures, nanowire networks of CPs, for example, polypyrrole (PPy) 
nanowire network, have attracted a great deal of interest due to their wide 
applications in the ﬁelds of biosensors, energy source, and electronics [3,4]. 
However, there are few reports on the use of PPy nanowire work for controlled drug 
release. Recently, our group extended the application of PPy nanowire network to this 
ﬁeld, obtaining an effective drug release system with high adenosine triphosphate 
(ATP) release efﬁciency [5]. 
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It is well known that CPs can be used as drug carriers due to their unique doping–
dedoping and stimulus–responsive property [6–22], where drugs can be 
incorporated into CPs as dopants and then be released upon electrical stimulation. 
Therefore, the capacity of drug loading is dependent on the doping level (which is 
usually low) and the type of drugs is restricted to the charged and small molecules. 
Actually, relatively low drug loading capacity and limited range of drugs can be loaded 
have become two main obstacles for the practical applications of the current existing 
CP-based drug release systems. 
 
In the present work, we ﬁnd that the micro- and nano-gaps among the individual 
nanowires of the above mentioned PPy nanowire network can be used as reservoir to 
store drugs. Because the space for drug storage has changed from the backbones of the 
CPs to the vacancies among the nanowires, it is not necessary to consider the charge 
and the volume of the loaded drugs. Therefore, both the drug loading capacity and the 
range of loaded drugs can be improved signiﬁcantly. After being covered with a 
protective PPy ﬁlm for inhibiting drug leakage, controlled drug release from the 
prepared P–P system (drug-loading PPy nanowire network coated by a PPy ﬁlm) is 
achieved by electrical stimulation (cyclic voltammetry, CV) and the amount of drug 
released can be controlled by changing the scan rate of CV and the thickness of the 
protective PPy ﬁlm. 
 
2. Experimental 
2.1 Chemicals 
Pyrrole, para-toluene sulphonic acid sodium salt (p-TS), iron (III) chloride 
hexahydrate (FeCl3·6H2O), and dimethyl sulfoxide (DMSO) were obtained from 
Sinopharm Chemical Reagent Co., Ltd. (China). Pyrrole was distilled under the 
protection of nitrogen gas and stored at −20 ◦C. Hexadecane was got from Aladdin 
Chemistry Co., Ltd. (China). ATP and dexamethasone (Dex) were purchased from 
Sangon Biotech Co., Ltd. (China). Dopamine hydrochloride was bought from Sigma. 
Hydroxycamptothecin (HCPT) and paclitaxel were obtained from Li Shizhen Medicine 
Group Co., Ltd. (China). All other chemicals were of analytical grade and were used as 
received. All solutions were prepared using deionized Milli-Q water (Millipore). 
 
2.2.  Preparation of drug loaded PPy nanowire network 
The PPy nanowire network was synthesized electrochemically at room temperature 
with conventional three-electrode cell by the use of CHI600D Electrochemical 
Workstation (Shanghai CH instruments, China). A bare gold (Au, diameter of 4.0 
mm) was used as working electrode. The counter electrode was a platinum wire 
and a saturated calomel electrode (SCE) was used as the reference electrode. The 
electrolyte was an aqueous solution of 0.145 M pyrrole, 0.085 M p-TS and 0.200 M 
phosphate buffer solution (pH 7.40). Before the electropolymerization, the 
electrolyte solution was degassed with a nitrogen stream for 5 min. PPy nanowire 
network was grown for 1600 s from the surface of the Au electrode at 0.477 mA cm−2. 
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After polymerization, the working electrode was removed from the electrolyte and 
rinsed thoroughly with de-ionized water, and then dried in air at room 
temperature. 
 
6.0 µL aqueous solution containing 0.01 M ATP (or 0.01 M SSA, 0.02 M Dopamine) or 
10 µL DMSO solution containing 0.005 M Dex (or 6.0 µL DMSO of 0.01 M HCPT, 5 µL 
DMSO of 0.01 M Pacitaxel) was then dropped onto the surface of the PPy nanowire 
network and dried in air. 
 
2.3 Synthesis of the protective PPy ﬁlm by chemical vapor deposition (CVD) 
method 
To prevent the stored drugs from leaking, a PPy ﬁlm was polymerized on the top of the 
PPy nanowire network by CVD technique. The PPy nanowire network-coated Au 
electrode was mounted in a reaction vessel equipped with a sealing apparatus and a 
monomer injection port. 10, 15 and 20 µL ethanol solution containing 0.1 M FeCl3 
were dropped onto PPy nanowire network-coated Au electrode, respectively. The 
reaction chamber was vacuumized at room temperature until the internal pressure 
reduced to 10−2 Torr. Then, excessive pyrrole monomer was injected into the 
reactor with a micro-syringe. The pyrrole monomers were polymerized on the 
surface of the PPy nanowire network at 60 ◦C for 1 h. Subsequently, the obtained P–P 
system was washed with deionized water for several times and dried in air. 
 
2.4 Characterization and measurements 
The surface morphologies of the PPy nanowire network and the P–P system were 
examined by a scanning electron microscope (SEM, LEO1530, Germany) operated at 
20 kV. The wettability measurement of the PPy nanowire network was performed on 
a KRUSS FM 40 MK2 contact angle (CA) goniometer. The static contact angles were 
obtained using 3 µL water droplets or hexadecane droplets. Cyclic voltammetry (CV) 
test was performed from −0.9 to 0.6 V sweeping at a constant scan rate of 0.01 V/s. 
Fourier transform infrared (FTIR) spectroscopy was recorded on an Avatar 360 
spectrophotometer (Thermo Nicolet, USA). 
 
2.5.  Drug release 
Electrical stimulation of ATP release was carried out in 2 mL NaCl solution (0.9%) 
stirred with a magnetic stirring bar at room temperature, and performed by cycling the 
potential from −0.9 to +0.6 V at different scan rates. Samples were taken at speciﬁc 
times from the release medium, analyzed for ATP content by a UV/Vis 
Spectrophotometer (UV-1750, Shimadzu, Japan) at 259 nm, and replaced with an 
equal volume of fresh 0.9% NaCl solution. The spontaneous release of ATP was 
conducted in the same release medium except that the external electrical stimulation 
was not applied. 
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Electrical stimulation of Dex release was carried out in 6 mL NaCl solution (0.9%) 
stirred with a magnetic stirring bar at room temperature, and performed by cycling the 
potential from −0.9 to +0.6 V at a scanning rate of 100 mV/s. Samples were taken at 
speciﬁc times from the release medium, analyzed for Dex content by the same 
UV/Vis Spectrophotometer at 242 nm, and replaced with an equal volume of fresh 
0.9% NaCl solution. The spontaneous release of Dex was conducted in the same release 
medium except that the external electrical stimulation was not applied. 
 
 
 
3. Results and discussion 
Scheme 1 shows the schematic representation of the synthesis and the drug release 
processes of the P–P system. In the ﬁrst step (Scheme 1a), PPy nanowire network 
was synthesized by a simple one-step electrochemical method. SEM images of the 
PPy nanowire network are shown in Fig. 1. It can be seen clearly that the PPy 
nanowire network exhibits porous interwoven structures, which inspires us to 
explore whether drugs can be loaded within the micro- and nano-gaps of the porous 
nanowire network. 
 
For this purpose, the surface wettability of the PPy nanowire network was examined. 
As  shown  in  Fig.  2A,  when  a  droplet of water (3 µL) was deposited on the surface of 
the nanowire network, the water will penetrate into the vacancies among individual 
nanowires and the CA is about 5◦, which indicates a superhydrophilic behavior. In 
addition, the lipophilic property of the nanowire network was also investigated. It 
was found that the CA of hexadecane on the surface of nanowire network was about 
18◦ (Fig. 2B), showing excellent lipophilicity. Therefore, the prepared PPy nanowire 
network shows amphilicity and it is reasonable to deduce that both hydrophilic and 
lipophilic drugs can be loaded into the nanowire network. Here, several drugs, 
including hydrophilic drugs such as ATP, SSA, and Dopamine and lipophilic drugs such 
as Dex, HCPT and paclitaxel were examined and it was found that all of these drugs, 
either hydrophilic or lipophilic, could be loaded easily into the nanowire network. In the 
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following experiments, ATP and Dex were chosen as the model hydrophilic and 
lipophilic drugs respectively for various tests (Scheme 1b). 
 
To prevent the stored drug from leaking, a protective PPy ﬁlm on the surface of the 
PPy nanowire network should be required. 
 
 
 
However, if the ﬁlm was prepared in aqueous solution, some of the loaded drug would 
diffuse to the solution due to the concentration difference. Therefore, it is difﬁcult to 
quantify the loaded drug. To solve this problem, a protective PPy ﬁlm was 
polymerized on the surface of the nanowire network by CVD method in our experiment 
(Scheme 1c). Because the PPy ﬁlm was formed in the pyrrole vapor under vacuum and 
no solution was used, drug leakage was prohibited completely. Fig. 3 shows the 
http://repository.uwc.ac.za
6 
 
morphology of the protective PPy ﬁlm. It demonstrates that the ﬁlm has a dense and 
smooth surface and the nanostructures were faintly visible. 
 
After covering the nanowire network with the protective ﬁlm, the whole P–P system 
with ATP as model hydrophilic drug were characterized qualitatively by FTIR 
spectroscopy in the range of 400–4000 cm−1. The results are presented in Fig. 4. 
The absorption bands at 1568, 1477, 1331 and 1078 cm−1 are attributed to the PPy 
chain. The peak around 1568 cm−1 is associated with the pyrrole ring of the 
combination of C C and C C stretching vibrations. The band at 1477 cm−1 is assigned 
to the C N stretching vibration. The absorption peaks near 1078 and 1331 cm−1 are 
attributed to the deformation vibrations of C H and C N stretching vibrations, 
respectively. The presence of ATP in the PPy nanowire network is proved by the 
appearance of peaks at 1250 cm−1 (corresponding to the P O stretching vibration) and 
1085 cm−1 (corresponding to the P O stretching vibration). The absorption peaks at 
2925 and 2851 cm−1  were intensiﬁed due to the introduction of  CH2 and CH groups in 
ATP. 
 
The electrochemical property of the PPy nanowire network was evaluated by cyclic 
voltammetry in 0.9% NaCl aqueous solution (the naked Au electrode was also studied 
for comparison). As shown in Fig. 5, the current of naked Au electrode is close to zero 
and no obvious redox peaks were observed. In contrast, the PPy nanowire network 
has clearly redox peaks, which elucidate that PPy nanowire network has much 
better electrochemical activity than the naked Au electrode and thus beneﬁts to 
subsequent drug release. 
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After  the  deposition  of  the  protective  PPy  ﬁlm  on  the  PPy nanowire network, 
spontaneous release of ATP from this P–P system at open circuit was investigated 
(spontaneous release of ATP from PPy nanowire network was also examined for 
comparison). ATP release efﬁciency was plotted versus time, as shown in Fig. 6. It is 
observed that spontaneous ATP release from nanowire network is rather signiﬁcant. 
Nearly 99% of loaded ATP was released within 1 h. However, only 18% of ATP was 
released at open circuit within 10 h from the P–P system, which indicated that the 
presence of the outer protective PPy ﬁlm could signiﬁcantly inhibit the spontaneous 
ATP release. 
 
Then ATP release from the P–P system under CV electrical stimulation (Scheme 1d) was 
investigated. As shown in Fig. 6, it was found that the effect of scan rate of CV on the 
ATP release efﬁciency is signiﬁcant. About 57, 89 and 95% of ATP were released from 
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the P–P system at scanning rates of 50, 100, and 200 mV/s within 10 h, respectively. 
The results reveal that like the normal CP-based drug release systems (drugs were 
loaded by doping), drug release from the P–P system also can be performed by electrical 
stimulation and the drug release rates can be regulated by changing the CV scan rates. 
It is well known that when PPy was switched from the oxidized state to the reduced 
state, it was accompanied by a change in the PPy volume, from its expansion state to 
the contraction state [22,23]. Therefore, the diminishing of the PPy volume could 
provide the driving force for the expulsion of ATP. The faster the scan rate, the more 
frequent the contraction and expansion of the ﬁlm. As a result, more drugs were 
squeezed out. 
 
On the other hand, since the space for the CVD reaction is ﬁxed, if the amount of the 
pyrrole is excessive and the polymerization time is long enough, the thickness of the 
outer protective PPy ﬁlm will be proportional to the oxidant consumption. In our 
experiment, three protective PPy ﬁlms with different thicknesses were prepared by 
changing the oxidant amounts. As expected, it was observed that the amount of ATP 
released decreased with the increase of the thickness of the outer protective PPy ﬁlm. 
About 91, 66, and 44% of ATP were released from the systems with the protective PPy 
ﬁlms synthesized by consuming 10, 15, and 20 µL oxidant solutions (0.1 M FeCl3) in 
12 h, respectively, as shown in Fig. 7. 
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These results revealed that the ATP release efﬁciency also can be tuned by changing 
the thickness of the protective PPy ﬁlm. 
 
In our experiment, release of lipophilic drug Dex from the P–P system was also 
examined. The results present in Fig. 8 show that 95% of Dex was released under CV 
electrical stimulation from −0.9 to 0.6 V at a scanning rate of 100 mV/s while only 
15% of Dex was diffused from the system at open circuit, indicating that the release of 
lipophilic drug could also be controlled effectively by the present system. 
 
4.  Conclusion 
A PPy-based drug release system was developed by deposition of a protective PPy ﬁlm 
on the surface of PPy nanowire network. The PPy nanowire network was synthesized 
by a simple one-step electrochemical method. It was found that micro- or nano-
gaps among the individual nanowires could be used as reservoirs to store drugs. 
Interestingly, both hydrophilic and lipophilic drugs could be loaded into the system 
by taking advantage of amphilicity of the PPy nanowire network and subsequently be 
released upon electrical stimulation. The amount of the drug released could be 
controlled by changing the scan rate of the CV and the thickness of the outer protective 
PPy ﬁlm. In summary, the drug release system prepared here not only keeps the 
advantage of the conventional PPy-based drug release system (drug release can be 
performed by electrical stimulation), but also provides some new merits. For example, 
higher drug loading capacity is achieved and more type of drugs can be loaded. 
Furthermore, other related functional materials such as drug-loading nanoparticles 
may also be stored within the PPy nanowire network and thus offer a new strategy for 
easily incorporation of drugs or drug carriers. It is expected that this PPy nanowire 
network based drug release system may have great potential for future clinical 
applications where high drug loading capacity is required. 
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